Skip to main content

Iodine-125 Implantation for Prostatic Carcinoma

  • Chapter
Cancer of the Prostate and Kidney

Part of the book series: NATO Advanced Science Institutes Series ((NSSA,volume 53))

  • 63 Accesses

Abstract

The technique and rationale for iodine 125 implantation for prostatic adenocarcinoma has been fully described by its originators (1). This article will be devoted to recent modifications and continuing controversies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. W. Barzell, M.A. Bean, B.S. Hilaris, and W.F. Whitmore, Jr. Prostatic adenocarcinoma: Relationship of grade and local extent of metastases, J.Urol. 118:278 (1977).

    PubMed  CAS  Google Scholar 

  2. J.E. Fowler, Jr., W. Barzell, B.S. Hilaris, and W.F. Whitmore, Jr., Complications of 125 iodine implantation and pelvic lymphadenectomy in the treatment of prostatic cancer, J.Urol. 121:447 (1979), p.171.

    PubMed  Google Scholar 

  3. D.F. Gleason, Histologic grading and clinical staging of prostatic carcinoma, in: “The Prostate,” M. Tannenbaum, ed., Lea and Febiger, Philadelphia (1977).

    Google Scholar 

  4. W.U. Shipley, G. Kopelson, D.H. Novack. C.C. Ling, S.P. Dretler and G.R. Prout, Jr., Preoperative irradiation, lymphadenectomy and 125 iodine implant for patients with localized prostatic carcinoma: A correlation of implant dosimetry with clinical results, J.Urol. 124:639 (1980).

    PubMed  CAS  Google Scholar 

  5. B.S. Hilaris, W.F. Whitmore, Jr., M.A. Batata, W. Barzell, and N. Tokita, Iodine 125 implantation of the prostate: dose-response considerations, Front. Rad. Ther. 12:82 (1978).

    Google Scholar 

  6. B. Lytton, J.T. Collins, R.M. Weiss, M. Schiff, Jr., E.J McGuire, and V. Livolsi, Results of biopsy after early stage prostatic cancer treatment by implantation of iodine seeds, J.Urol. 121: 306 (1979).

    PubMed  CAS  Google Scholar 

  7. H.W. Herr, Preservation of sexual potency in prostatic cancer patients after pelvic lymphadenectomy and retropubic 125 implantation, J.Urol. 121:621 (1979).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer Science+Business Media New York

About this chapter

Cite this chapter

Macchia, R.J. (1983). Iodine-125 Implantation for Prostatic Carcinoma. In: Pavone-Macaluso, M., Smith, P.H. (eds) Cancer of the Prostate and Kidney. NATO Advanced Science Institutes Series, vol 53. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4349-3_37

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-4349-3_37

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-4351-6

  • Online ISBN: 978-1-4684-4349-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics